Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
04/2012
04/11/2012CN102408485A 血小板生成素模拟肽二联体与人血清白蛋白的融合蛋白及其制备方法和应用 Human serum albumin fusion thrombopoietin mimetic peptide two conjoined protein and its preparation method and application
04/11/2012CN102408483A Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors
04/11/2012CN102408476A 捕光叶绿素a/b结合蛋白基因及其在提高植物产量和种子含油量中的应用 Light-harvesting chlorophyll a / b binding protein gene and its application in improving plant yield and seed oil content of
04/11/2012CN102408475A Bt protein Cryt1Da1, and coding gene and application thereof
04/11/2012CN102408474A Bt protein Cry69Aa1, and coding gene and application thereof
04/11/2012CN102408473A 一种Bt蛋白Cyt3Aa1、其编码基因及应用 One kind of Bt protein Cyt3Aa1, its coding gene and application
04/11/2012CN102408472A 一种Bt蛋白Cry62Aa1、其编码基因及应用 One kind of Bt protein Cry62Aa1, its coding gene and application
04/11/2012CN102408470A Synthetic peptides for use as inhibitors of neurotransmitter secretion and as inducers of cellular relaxation
04/11/2012CN102406944A 抗ku70内化的抗体 Within the anti-ku70 antibodies
04/11/2012CN102406926A 一种聚酯类纤维载体培养细胞以制备病毒或生产疫苗的方法 A method of polyester fiber carrier cultured cells to produce virus or vaccine production
04/11/2012CN102405846A Mutated acetohydroxyacid synthase genes in brassica
04/11/2012CN101343640B 共表达CTLA4Ig和CTLA4的重组腺病毒载体、重组腺病毒及其应用 Co-expression of CTLA4Ig and CTLA4 recombinant adenovirus vector, recombinant adenovirus and its applications
04/10/2012US8153870 Rice hybrid XL745
04/10/2012US8153869 Maize variety hybrid X7H208
04/10/2012US8153868 Maize variety hybrid X7M675
04/10/2012US8153867 Maize variety inbred PH13CH
04/10/2012US8153859 DGAT genes from oleaginous organisms for increased seed storage lipid production and altered fatty acid profiles in oilseed plants
04/10/2012US8153858 Sale of fluorescent transgenic ornamental fish
04/10/2012US8153776 Using targeted gene expression inhibition to treat and prevent viral infection
04/10/2012US8153775 Kits for detecting rank
04/10/2012US8153774 Human T1R2 taste receptor nucleic acids and cells containing these nucleic acids
04/10/2012US8153596 Use of SH2 STAT3/STAT1 peptidomimetics as anticancer drugs
04/10/2012US8153433 Mammalian cell lines for increasing longevity and protein yield from a cell culture
04/10/2012US8153431 Using both insertional and physiochemical means to generate stable, genetic rearrangement in cells; tissue engineering
04/10/2012US8153430 Methods related to surgery
04/10/2012US8153429 Nutrient broth comprising estrogen receptor ligand for use in propagation and specialization of cells
04/10/2012US8153428 Use of TGF beta superfamily antagonists and neurotrophins to make neurons from embryonic stem cells
04/10/2012US8153427 Cardiomyocytes and methods of producing and purifying cardiomyocytes
04/10/2012US8153426 Preparation of antigen-presenting human gamma-delta T cells and use in immunotherapy
04/10/2012US8153425 Dendritic cell compositions and methods
04/10/2012US8153424 Method of in vitro differentiation of neural stem cells, motor neurons and dopamine neurons from primate embryonic stem cells
04/10/2012US8153423 Pluripotent cells from the mammalian late epiblast layer
04/10/2012US8153422 Dopaminergic neurons differentiated from embryonic cells for treating neurodegenerative diseases
04/10/2012US8153421 Prostate stem cell
04/10/2012US8153411 Dehalogenases, nucleic acids encoding them and methods for making and using them
04/10/2012US8153398 Polynucleotides encoding signal peptide-containing molecules
04/10/2012US8153388 Methods for phenotyping of leukemias
04/10/2012US8153386 Human T2R64 taste receptor and related assays for identifying human bitter taste modulators
04/10/2012US8153384 Marks as modifiers of the p53 pathway and methods of use
04/10/2012US8153359 Toxicity assay based on human blastocyst-derived stem cells and progenitor cells
04/10/2012US8153147 Heparin coating of biological tissue
04/10/2012US8153141 Immunostimulatory G, U-containing oligoribonucleotides
04/10/2012US8153138 Recombinant MVA virus
04/10/2012US8153129 Antibodies against human cytimegalovirus (HCMV)
04/10/2012US8153126 Anti-αvβ6 antibodies
04/10/2012US8153124 Method for treating cancer using monoclonal antibodies
04/10/2012US8153118 Method for altering the metabolism of plant
04/10/2012US8153117 Genetically altered chondrocyte expresses a therapeutic agent; implanting a biocompatible substrate into a target region; brain, heart, liver, kidney, intestinal tract, spleen, smooth and skeletal muscles, eye, ganglions, lungs, gonads, pancreas
04/10/2012US8153113 Method of increasing trafficking of endothelial progenitor cells to ischemia-damaged tissue
04/10/2012CA2631345C Method of producing chitosan scaffold having high tensile strength and chitosan scaffold produced using the method
04/10/2012CA2549564C Tissue preservation media
04/10/2012CA2537861C Entrapped stem cells and uses thereof
04/10/2012CA2534349C Human skin equivalents expressing exogenous polypeptides
04/10/2012CA2501965C Ultrafiltration membrane, device, bioartificial organ, and methods
04/10/2012CA2445253C Single chain camelid vhh antibodies, method for their production in a mammal, and their uses
04/10/2012CA2438921C Streptococcus pyogenes polypeptides and corresponding dna fragments
04/10/2012CA2432329C Lipase variants
04/10/2012CA2412035C Hcv antigen/antibody combination assay
04/10/2012CA2399432C Cytotoxic t lymphocytes activated by dendritic cell hybrids
04/10/2012CA2395713C G-csf conjugates
04/10/2012CA2385325C Chlamydia antigens and corresponding dna fragments and uses thereof
04/10/2012CA2353086C Pgc-1, a novel brown fat ppar.gamma. coactivator
04/10/2012CA2335142C Process for conversion of germplasm
04/10/2012CA2330660C Muscle-derived cell mediated gene delivery for treating muscle-and bone-related injury or dysfunction
04/08/2012CA2745860A1 Surgical compositions
04/05/2012WO2012045097A1 Production of dentin, cementum and enamel by cells
04/05/2012WO2012045096A2 Compositions and methods of forming cardiac progenitor cells
04/05/2012WO2012045094A1 Derivation of fibrochondrocytes from progenitor cells
04/05/2012WO2012045093A1 Compositions and methods for cell homing and adipogenesis
04/05/2012WO2012045086A1 Pdgf induced cell homing
04/05/2012WO2012045075A1 Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
04/05/2012WO2012044992A2 Methods and reagents for detection and treatment of esophageal metaplasia
04/05/2012WO2012044979A2 Manipulation of stem cell function by p53 isoforms
04/05/2012WO2012044933A2 B and t lymphocyte attenuator marker for use in adoptive t-cell therapy
04/05/2012WO2012044836A1 Variants of polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
04/05/2012WO2012044835A1 Variants of polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
04/05/2012WO2012044486A1 Induction of pancreatic stem cells by transient overexpression of reprogramming factors and pdxi selection
04/05/2012WO2012044139A2 Novel use of cryptotanshinone
04/05/2012WO2012043814A1 Method for differentiating human-derived pluripotent stem cells
04/05/2012WO2012043755A1 Cis-acting element and utilization thereof
04/05/2012WO2012043653A1 Novel transaminase showing high activity for glutamic acid, gene encoding same, and method for utilization thereof
04/05/2012WO2012043651A1 Production method for myeloid blood cells
04/05/2012WO2012043634A1 Antibody against human prostaglandin e2 receptor ep4
04/05/2012WO2012043622A1 Novel aminotransferase and gene encoding same, and use of the aminotransferase and the gene
04/05/2012WO2012043601A1 Amadoriase variant
04/05/2012WO2012043533A1 Antihuman ccr7 antibodies, hybridoma, nucleic acid, vector, cell, medicinal composition, and antibody-immobilized carrier
04/05/2012WO2012043477A1 Linker for unimolecular fret biosensor based on principle of fluorescence resonance energy transfer
04/05/2012WO2012042684A1 Method for transporting potassium ions from outside to inside of a lipid bilayer
04/05/2012WO2012042519A1 Methods of obtaining cell populations enriched with desired cells
04/05/2012WO2012042459A1 Magnetised stem cells and use thereof
04/05/2012WO2012041768A1 Production of low fucose antibodies in h4-ii-e rat cells
04/05/2012WO2012041522A1 Device and method for the production of 3d structures in layers, and use thereof
04/05/2012WO2012041320A1 Implantable cell device with supportive and radial diffusive scaffolding
04/05/2012WO2012018607A3 Vectors and methods for recombinant protein expression
04/05/2012WO2012014190A3 Compositions and methods for prognosis of mesothelioma
04/05/2012WO2012009544A3 Domain insertion immunoglobulin
04/05/2012WO2012006577A3 Direct reprogramming of cells to cardiac myocyte fate
04/05/2012WO2012006440A3 Endothelial cell production by programming
04/05/2012WO2012003450A3 Biomatrix scaffolds
04/05/2012WO2011142545A3 Method for inhibiting the induction of cell death by inhibiting the synthesis or secretion of age-albumin in cells of the mononuclear phagocyte system